LeserbriefOpen Access · CC BY 4.0
Genetic and molecular advancements in combined hepatocellular-cholangiocarcinoma: Addressing a persistent clinical conundrum
EXCLI Journal · 20.08.2026 · 25 · 1388-1391
DOI: 10.17179/excli2026-9655 ↗Kurz gefasst
Leserbrief in der Zeitschrift EXCLI Journal, online erschienen am 20.08.2026. Verfasst von Rabab Fatima. Beteiligte Einrichtung: School of Health Sciences & Technology, UPES, Dehradun 248007, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Health Sciences & Technology, UPES, Dehradun 248007, India.
Zitieren
APA
Fatima, R. (2026). Genetic and molecular advancements in combined hepatocellular-cholangiocarcinoma: Addressing a persistent clinical conundrum. EXCLI Journal, 25, 1388-1391. https://doi.org/10.17179/excli2026-9655
Vancouver
Fatima R. Genetic and molecular advancements in combined hepatocellular-cholangiocarcinoma: Addressing a persistent clinical conundrum. EXCLI Journal. 2026;25:1388-1391. doi:10.17179/excli2026-9655
BibTeX
@article{Fatima2026,
author = {Fatima, Rabab},
title = {Genetic and molecular advancements in combined hepatocellular-cholangiocarcinoma: Addressing a persistent clinical conundrum},
journal = {EXCLI Journal},
year = {2026},
volume = {25},
pages = {1388--1391},
doi = {10.17179/excli2026-9655}
}
EUVIMED